Ann Thorac Surg 2001;72:219-220
© 2001 The Society of Thoracic Surgeons
Invited commentary
Mark K. Ferguson, MDa
a Department of Surgery, The University of Chicago, Medical Center, 5841 S Maryland Ave, MC 5035, Chicago, IL 60637, USA
e-mail: mferguso@surgery.bsd.uchicago.edu
Diagnosis precedes therapy, and, for most carcinomas, staging should also precede therapy. Until recently, the latter aphorism has not been applicable to esophageal cancer because of the inaccuracy of available staging studies. A recent expedited review of information regarding the utility of positron emission tomography (PET) in staging esophageal cancer led to its approval for this purpose at the end of 2000 by the Health Care Financing Administration. In contrast, endoscopic ultrasonography (EUS) has been available for a decade for staging esophageal cancer. However, its role . . . [Full Text of this Article]
Related Article
-
Predictors of survival for esophageal cancer patients with and without celiac axis lymphadenopathy: impact of staging endosonography
- Mohamad A. Eloubeidi, Michael B. Wallace, Brenda J. Hoffman, Margaret B. Leveen, Annette Van Velse, Robert H. Hawes, and Carolyn E. Reed
Ann. Thorac. Surg. 2001 72: 212-219.
[Abstract]
[Full Text]
[PDF]
Copyright © 2001 by The Society of Thoracic Surgeons.